Atremia 0,5 mg tvrde kapsule
Name | Atremia 0,5 mg tvrde kapsule |
---|---|
Marketing Authorisation Number | HR-H-094685523 |
Active Substance | anagrelidklorid hidrat |
Composition | jedna kapsula sadrži 0,5 mg anagrelida (u obliku anagrelidklorid hidrata) |
Pharmaceutical Form | kapsula, tvrda |
Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska Synthon BV, Nijmegen, Nizozemska Teva Operations Poland Sp. z o.o., Krakow, Poljska Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
Marketing Authorisation Date | 27.06.2022 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/21-02/190 |
Registration Number | 381-12-01/14-22-07 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01XX35 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o riziku od tromboze, uključujući cerebralni infarkt, nakon naglog prekida liječenja anagrelidom | 11.03.2022 | Stada d.o.o., Pliva Hrvatska d.o.o., Alpha-Medical d.o.o., Zentiva k.s., AOP Orphan Pharmaceuticals GmbH |